dual Mab therapyRheumatoid Arthritisankylosing spondylitisPsoriasisosteoporosisbenralizumabadalimumabmepolizumabinflammatory bowel disease
…b. Eight patients retained good asthma control whilst receiving dual Mab therapy, with one patient stopping mepolizumab at 12 months due to poor…